| According to a study released by the company Tuesday, the Moderna vaccine was 93% effective against COVID-19 in children aged 12 to 17 after the first dose and 100% effective two weeks after the second dose, with no cases of COVID-19 reported among vaccinated participants. Moderna said the trial involved more than 3,700 adolescents, two-thirds of whom received the vaccine and one-third of whom were given a placebo. |  |
News Alert Tuesday, May 25 | | |  | | Moderna says its COVID vaccine found to be 100% effective in children 12 to 15 after the second dose | | According to a study released by the company Tuesday, the Moderna vaccine was 93% effective against COVID-19 in children aged 12 to 17 after the first dose and 100% effective two weeks after the second dose, with no cases of COVID-19 reported among vaccinated participants. Moderna said the trial involved more than 3,700 adolescents, two-thirds of whom received the vaccine and one-third of whom were given a placebo. | | | | | | | | | | | |
